Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2014
04/23/2014CN101511819B N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
04/22/2014US8704215 Stilbene derivatives, light-emitting element, display device, and electronic device
04/22/2014US8703945 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
04/22/2014US8703938 Hepatitis C virus inhibitors
04/22/2014US8703771 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
04/22/2014US8703768 Nitrogen containing heteroaryl compounds
04/22/2014US8703767 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors
04/22/2014US8703761 Organic compounds
04/22/2014US8703758 Bicyclic compound
04/22/2014US8703721 Arylalkylamine compound and process for preparing the same
04/22/2014US8703305 Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
04/22/2014CA2659696C 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
04/22/2014CA2637771C Anthranilamide/2-amino-heteroarene carboxamide derivatives
04/22/2014CA2623360C Squaric acid derivatives as inhibitors of histone deacetylase
04/22/2014CA2612227C Pyrimidine compounds
04/22/2014CA2597813C Chemical compounds
04/22/2014CA2589192C Phenyl-piperazin methanone derivatives
04/17/2014WO2014059368A1 Companion diagnostics for tec family kinase inhibitor therapy
04/17/2014WO2014058747A1 5-phenoxy-3h-pyrimidin-4-one derivatives and their use as hiv reverse transcriptase inhibitors
04/17/2014WO2014058268A1 Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
04/17/2014WO2014057772A1 Novel pyrazole derivative
04/17/2014WO2014057435A1 Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
04/17/2014WO2014057080A2 Cyclic amines
04/17/2014WO2014057078A1 Benzamides
04/17/2014WO2014056852A1 Labeled ligands of the oxytocin receptor
04/17/2014WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors
04/17/2014US20140107340 Benzamides
04/17/2014US20140107338 Novel organic electroluminescent compounds and organic electroluminescent device using the same
04/17/2014US20140107335 Cyclic Amines
04/17/2014US20140107327 Methods for preparing deuterated 1,2,3-triazoles
04/17/2014US20140107172 Benzimidazole-imidazole derivatives
04/17/2014US20140107164 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
04/17/2014US20140107128 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/17/2014US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics
04/17/2014US20140107120 Dual-acting benzoimidazole antihypertensive agents
04/17/2014US20140107111 Use of sigma ligands in diabetes type-2 associated pain
04/16/2014EP2718285A1 Hydantoin derivates as kv3 inhibitors
04/16/2014EP2718284A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
04/16/2014EP2718270A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
04/16/2014CN103732591A Biscarbazole derivative and organic electroluminescence element using same
04/16/2014CN103732590A Novel compounds for organic electronic material and organic electroluminescent device using same
04/16/2014CN103732589A Substituted sulfonamides useful as antiapoptotic BCL inhibitors
04/16/2014CN103732579A Process for the synthesis of N-substituted cyclic alkylene ureas
04/16/2014CN103728294A Applications of bisbenzimidazole bicarbazole compound in specific binding nucleic acid G-quadruplex structure and anti-tumor drug
04/16/2014CN103724331A Compound for treating cerebral palsy and use thereof
04/16/2014CN103724330A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
04/16/2014CN103724328A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
04/16/2014CN103059001B Quinazolinone Schiff base containing triazole and preparation method thereof
04/16/2014CN102803250B 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17
04/16/2014CN102666528B Crystalline CDC7 inhibitor salts
04/16/2014CN102574836B Aminopyrazole derivative
04/16/2014CN102574835B Compounds useful for treating cancer
04/16/2014CN102548987B Fluoro-substituted compounds as kinase inhibitors and methods of use thereof
04/16/2014CN102498109B Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonist
04/16/2014CN102245597B Compounds useful for inhibiting CHK1
04/16/2014CN102171207B Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
04/16/2014CN101801960B Prodrugs to thyroid hormone analogs
04/16/2014CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
04/16/2014CN101578261B Heteroaryl-substituted serine amides
04/15/2014US8697888 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
04/15/2014US8697886 Di(aminoguanidium) 4,4′,5,5′-tetranitro-2,2′-biimidazole, and preparation method thereof
04/15/2014US8697870 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
04/15/2014US8697865 Cyclic amide derivative, and its production and use
04/15/2014US8697737 Raf modulators and methods of use
04/15/2014US8697736 1H-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
04/15/2014US8697717 Inhibitors of histone deacetylase
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697696 Triazole compounds II
04/15/2014US8697689 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
04/10/2014WO2014055647A1 (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
04/10/2014WO2014055548A1 Anti-fibrotic pyridinones
04/10/2014WO2014055069A1 Solid forms comprising an inhibitor of hcv ns5a, compositions thereof, and uses therewith
04/10/2014WO2014054912A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same
04/10/2014WO2014054634A1 Pyrimidine derivative
04/10/2014WO2014054596A1 Organic electroluminescent element, organic el lighting and organic el display device
04/10/2014WO2014054263A1 Material for organic electroluminescent element, and organic electroluminescent element produced using same
04/10/2014WO2014053473A1 1,2,4-triazine-3,5-dione-6-carboxamides and use thereof as herbicide
04/10/2014WO2014053409A1 Benzimidazol.es as cns active agents
04/10/2014WO2012075114A3 Nucleic acid-polymer conjugates and uses thereof
04/10/2014US20140100231 Non-nucleoside reverse transcriptase inhibitors
04/10/2014US20140100215 Methods of Using PI3K and MEK Modulators
04/10/2014US20140100214 Heterocyclic compounds and uses thereof
04/10/2014US20140100213 Triazolones as fatty acid synthase inhibitors
04/10/2014US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof
04/10/2014US20140099518 Lubricants for data storage
04/09/2014EP2716638A1 Labeled ligands of the oxytocyn receptor
04/09/2014EP2716633A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof
04/09/2014EP2714681A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
04/09/2014EP2714680A1 Heterocyclic autotaxin inhibitors and uses thereof
04/09/2014EP2714679A1 Novel imidazole derivatives useful for the treatment of arthritis
04/09/2014EP2714662A1 Neprilysin inhibitors
04/09/2014EP2714092A1 Immunoconjugates, compositions containing them, and methods of making and use
04/09/2014CN103717602A Kinase inhibitors
04/09/2014CN103717589A Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
04/09/2014CN103717588A Novel pyrazole derivative
04/09/2014CN103710021A Fluorescent dye with nitrobenzimidazole as RNA (ribonucleic acid) recognition group as well as preparation method and application of fluorescent dye
04/09/2014CN103709154A Benzimidazole derivatives, preparation method and medicinal use thereof
04/09/2014CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs
04/09/2014CN103709150A A besigliptin tosilate crystal form, a preparation method there and applications thereof
04/09/2014CN103709149A A besigliptin tosilate crystal form, a preparation method there and applications thereof
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 626